# ANDA219953
> **ANDA219953** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMACEUTICALS · Approved 2026-08-20
## Drug
- **FDA Application Number:** ANDA219953
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** —
- **Generic name:** —
- **Active ingredients:** —
- **Dosage form:** —
- **Route:** —
- **Marketing status:** —
- **Sponsor:** SCIEGEN PHARMACEUTICALS
- **First approval:** 2026-08-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219953)
---
*MORVS · CC0 1.0*